Amphetamine Tablet, Orally Disintegrating
Product Images NDC 0480-3317
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Amphetamine (NDC 0480-3317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Image 2)
1 (Image 3)
This is a medication label for Amphetamine Extended-Release orally disintegrating tablets with instructions not to crush or chew the tablets. It also indicates the NDC number and advises the pharmacist to dispense the accompanying Medication Guide to each patient. The label further specifies the quantity of tablets and provides additional details regarding prescription and usage.*
1 (Image 4)
1 (Image 5)
1 (Image 6)
This text appears to be a description for a medication called "Amphetamine Extended-Release Orally Disintegrating Tablets". The instructions on the label advise not to crush or chew the tablets. The text also mentions a pharmacist should dispense the accompanying Medication Guide to each patient. The package contains 30 unit-dose tablets.*
1 (Image 7)
1 (Image 8)
This text appears to be information about a medication called Amphetamine Extended-Release Orally Disintegrating Tablets. The text includes instructions not to crush or chew the tablets, information on the tablet dosage, and a mention of dispensing a medication guide to patients. The text also contains NDC numbers related to this product.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.